Publications by authors named "Laura Lozza"

Claim this Profile
R
Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer.
Riccardo Ray Colciago, Daniele Presti, Carlotta Giandini, Eliana La Rocca, Maria Grazia Carnevale, Laura Lozza

Discov Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy.
Meritxell Arenas, Yasemin Bölükbaşı, Liesbeth J Boersma, Birgitte Offersen, Vassilis Kouloulias, Laura Lozza

Breast· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial.
Roberto Agresti, Marco Sandri, Giuseppe Capri, Giulia Bianchi, Tiziana Triulzi, Laura Lozza

Br J Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics to predict tumor response to combination chemoradiotherapy in squamous cell carcinoma of the anal canal: a preliminary investigation.
Andrea Vanzulli, Lucilla Violetta Sciacqua, Filippo Patti, Roza Drebot, Eros Montin, Laura Anna Maria Lozza

Eur Radiol Exp· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients.
Francesca Ligorio, Andrea Vingiani, Tommaso Torelli, Caterina Sposetti, Lorenzo Drufuca, Laura Lozza

Cell Metab· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Voices: Multimethod Study on the Feasibility of Implementing Electronic Patient-Reported Outcome Measures in a Comprehensive Cancer Center.
Cinzia Brunelli, Sara Alfieri, Emanuela Zito, Marco Spelta, Laura Arba, Laura Lozza

JMIR Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study.
Riccardo Ray Colciago, Eliana La Rocca, Carlotta Giandini, Maria Grazia Carnevale, Giulia Valeria Bianchi, Laura Lozza

Tumori· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Epigenetic immune monitoring for COVID-19 disease course prognosis.
Björn Samans, Marta Rosselló Chornet, Araceli Rosselló Chornet, Janine Jung, Konstantin Schildknecht, Laura Lozza

Front Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-week external beam partial breast irradiation: survival and toxicity outcomes.
Riccardo Ray Colciago, Eliana La Rocca, Carlotta Giandini, Alicia Rejas Mateo, Nice Bedini, Laura Lozza

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic immune monitoring for COVID-19 disease course prognosis.
Björn Samans, Marta Rosselló Chornet, Araceli Rosselló Chornet, Janine Jung, Konstantin Schildknecht, Laura Lozza

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis.
Carsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, Thordis Hohnstein, Christina Iwert, Laura Lozza

J Clin Invest· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement.
Riccardo Ray Colciago, Irene Fischetti, Carlotta Giandini, Eliana La Rocca, Tiziana Rancati T, Laura Lozza

Expert Rev Anticancer Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AIRO Breast Cancer Group .
Antonella Ciabattoni, Fabiana Gregucci, Fiorenza De Rose, Sara Falivene, Alessandra Fozza, Laura Lozza

Tumori· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability.
Justus Ninnemann, Caroline Winsauer, Marina Bondareva, Anja A Kühl, Laura Lozza

Mucosal Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4 T cells and is defective in Crohn´s disease patients.
Jonas Ahlers, Andrej Mantei, Laura Lozza, Manuela Stäber, Frederik Heinrich

Mucosal Immunol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort.
Mahmoud Aldraimli, Sarah Osman, Diana Grishchuck, Samuel Ingram, Robert Lyon, Laura Lozza

Adv Radiat Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer patient perspective on opportunities and challenges of a genetic test aimed to predict radio-induced side effects before treatment: Analysis of the Italian branch of the REQUITE project.
Lara Bellardita, Riccardo Ray Colciago, Sarah Frasca, Maria Carmen De Santis, Simona Gay, Laura Lozza

Radiol Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?
Riccardo Ray Colciago, Anna Cavallo, Maria Chiara Magri, Angelo Vitullo, Eliana La Rocca, Laura Lozza

Med Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.
Massimiliano Gennaro, Chiara Listorti, Luigi Mariani, Marco Maccauro, Giulia Bianchi, Laura Lozza

Eur J Surg Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
Fiorenza De Rose, Maria Carmen De Santis, Bruno Meduri, Ciro Franzese, Davide Franceschini, Laura Lozza

J Cancer Res Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular stress promotes NOD1/2-dependent inflammation via the endogenous metabolite sphingosine-1-phosphate.
Gang Pei, Joanna Zyla, Lichun He, Pedro Moura-Alves, Heidrun Steinle, Laura Lozza

EMBO J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations.
Nicola Rocco, Giuseppe Catanuto, Michela Cinquini, Werner Audretsch, John Benson, Laura Lozza

Breast· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRC5 promotes transcription of genes and Vγ9Vδ2 T cell-mediated killing.
Anh Thu Dang, Juliane Strietz, Alessandro Zenobi, Hanif J Khameneh, Simon M Brandl, Laura Lozza

iScience· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Rossana Ingargiola, Maria Carmen De Santis, Nicola Alessandro Iacovelli, Nadia Facchinetti, Anna Cavallo, Laura Lozza

Radiat Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The simulation-CT: Radiotherapy's useful tool in the race against COVID-19 pandemic. A serendipity approach.
Angelo Vitullo, Maria Carmen De Santis, Alfonso Marchianò, Riccardo Valdagni, Laura Lozza

Radiother Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis